Make Informed Investment Decisions with Affordable Access to Experts
Another View: Understanding the disease, standard of care, current treatment paradigm and the unmet need in treating squamous cell carcinoma of the head and neckTicker(s): IOVA
Name: Dr Rafael Santana-Davila - MD
Institution: University of Washington
- Assistant Professor, University of Washington School of Medicine & medical oncologist at Seattle Cancer Care Alliance who specializes in treating lung and head and neck cancers.
- Manages 400 patients (total) with lung cancer, 30 patients with HNSCC and 30 patients with SCLC each month.
- Has been involved in numerous lung cancer clinical trials and research focuses on designing and implementing clinical trials that test new treatments in the battle against cancer.
Please describe your current practice, roughly how many patients with HNSCC do you currently manage?Added By: c_admin
What is your current firstline treatment option for HNSCC?Added By: c_admin
What are your thoughts on TIL therapy in this space, particularly Iovance's LN-145?Added By: c_admin
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.